| Year |
Citation |
Score |
| 2021 |
Mou E, Advani RH, von Eyben R, Rosenberg SA, Hoppe RT. Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies). International Journal of Radiation Oncology, Biology, Physics. 110: 444-451. PMID 33385495 DOI: 10.1016/j.ijrobp.2020.12.039 |
0.346 |
|
| 2020 |
Weil CR, Qian Y, Von Eyben R, Daadi SE, Corbelli KS, Rosenberg SA, Advani RH, Hoppe RT. Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation. Leukemia & Lymphoma. 61: 2428-2434. PMID 32476541 DOI: 10.1080/10428194.2020.1768385 |
0.448 |
|
| 2018 |
Moding EJ, Advani R, Rosenberg SA, Hoppe RT. Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 129: 507-512. PMID 30539763 DOI: 10.1016/J.Radonc.2018.06.033 |
0.491 |
|
| 2018 |
Lynch RC, Sundaram V, Desai M, Henry S, Wood D, Daadi S, Corbelli KS, Rosenberg S, Hoppe RT, Advani R. No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission Blood. 132: 615-615. DOI: 10.1182/Blood-2018-99-113156 |
0.432 |
|
| 2018 |
Moding E, Advani R, Rosenberg S, Hoppe R. Prognostic Factors and Patterns of Failure in Advanced Stage Hodgkin Lymphoma Treated with Stanford V and Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: S189-S190. DOI: 10.1016/J.Ijrobp.2018.07.077 |
0.386 |
|
| 2018 |
Weil C, Qian Y, Von Eyben R, Daadi S, Corbelli K, Rosenberg S, Advani R, Hoppe R. The Outcomes of Patients with Unfavorable Stage I-II Classic Hodgkin Lymphoma Treated with Stanford V Chemotherapy and Limited Irradiation International Journal of Radiation Oncology*Biology*Physics. 102: S189. DOI: 10.1016/J.Ijrobp.2018.07.076 |
0.463 |
|
| 2015 |
Hoppe RT, Rosenberg SA. The Paris conference "La Radiothérapie de la Maladie de Hodgkin": a first step in the cure of Hodgkin disease. International Journal of Radiation Oncology, Biology, Physics. 92: 3-4. PMID 25863747 DOI: 10.1016/J.Ijrobp.2015.01.027 |
0.377 |
|
| 2013 |
Tan D, Horning SJ, Hoppe RT, Levy R, Rosenberg SA, Sigal BM, Warnke RA, Natkunam Y, Han SS, Yuen A, Plevritis SK, Advani RH. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 122: 981-7. PMID 23777769 DOI: 10.1182/Blood-2013-03-491514 |
0.461 |
|
| 2013 |
Koontz MZ, Horning SJ, Balise R, Greenberg PL, Rosenberg SA, Hoppe RT, Advani RH. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 592-8. PMID 23295809 DOI: 10.1200/Jco.2012.44.5791 |
0.377 |
|
| 2013 |
Advani RH, Hoppe RT, Baer D, Mason J, Warnke R, Allen J, Daadi S, Rosenberg SA, Horning SJ. Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1044-8. PMID 23136225 DOI: 10.1093/Annonc/Mds542 |
0.518 |
|
| 2011 |
Advani RH, Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ. Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience. International Journal of Radiation Oncology, Biology, Physics. 81: 1374-9. PMID 20934280 DOI: 10.1016/J.Ijrobp.2010.07.041 |
0.54 |
|
| 2010 |
Maeda LS, Hoppe RT, Rosenberg SA, Horning SJ, Advani RH. Outcome of Patients with Advanced Hodgkin Lymphoma Who Are Either Refractory to or Relapsed After Primary Therapy with the Stanford V Regimen Blood. 116: 4828-4828. DOI: 10.1182/Blood.V116.21.4828.4828 |
0.435 |
|
| 2010 |
Tseng D, Rachakonda L, Su Z, Advani R, Horning S, Rosenberg S, Hoppe R, Quon A, Graves E, Loo B, Tran P. Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease International Journal of Radiation Oncology*Biology*Physics. 78: S546-S547. DOI: 10.1016/J.Ijrobp.2010.07.1275 |
0.403 |
|
| 2009 |
Kohrt H, Johannsen A, Hoppe R, Horning SJ, Rosenberg SA, Advani R, Lee PP. Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease. Oncology Research. 18: 287-92. PMID 20225766 DOI: 10.3727/096504009X12596189659169 |
0.375 |
|
| 2009 |
Kohrt HE, Advani R, Hoppe R, Rosenberg S, Horning S, Lee PP. Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease Journal of Clinical Oncology. 27: 8573-8573. DOI: 10.1200/Jco.2009.27.15_Suppl.8573 |
0.301 |
|
| 2009 |
Advani RH, Hoppe RT, Baer DM, Mason J, Rosenberg SA, Horning SJ. Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial. Blood. 114: 1670-1670. DOI: 10.1182/Blood.V114.22.1670.1670 |
0.506 |
|
| 2009 |
Maeda LS, Horning SJ, Iagaru AH, Lin FI, Hoppe RT, Rosenberg SA, Advani RH. Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience. Blood. 114: 1563-1563. DOI: 10.1182/Blood.V114.22.1563.1563 |
0.397 |
|
| 2008 |
Tan D, Rosenberg SA, Lavori P, Sigal BM, Levy R, Hoppe RT, Warnke R, Advani R, Natkunam Y, Plevritis SK, Horning SJ. Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 8535. PMID 27951171 DOI: 10.1200/Jco.2008.26.15_Suppl.8535 |
0.401 |
|
| 2008 |
Rosenberg SA. Follicular lymphoma revisited. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 515-6. PMID 18235110 DOI: 10.1200/Jco.2007.13.8131 |
0.368 |
|
| 2007 |
Advani R, Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3902-7. PMID 17664458 DOI: 10.1200/Jco.2007.11.9867 |
0.347 |
|
| 2007 |
Horning SJ, Hoppe RT, Advani RH, Breslin S, Allen J, Hancock SL, Rosenberg SA. A prospective trial of involved field radiation (IFRT) + chemotherapy compared to extended field (EFRT) radiation for favorable Hodgkin disease: Survival differences and implications of mature follow-up for current combined modality therapy Journal of Clinical Oncology. 25: 8014-8014. DOI: 10.1200/Jco.2007.25.18_Suppl.8014 |
0.5 |
|
| 2007 |
Tan D, Rosenberg SA, Levy R, Lavori P, Tibshirani R, Hoppe RT, Warnke R, Advani R, Natkunam Y, Yuen A, Horning SJ. Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003. Blood. 110: 3428-3428. DOI: 10.1182/Blood.V110.11.3428.3428 |
0.484 |
|
| 2007 |
Advani RH, Hoppe RT, Rosenberg SA, Horning SJ. Stage I/II Hodgkin’s Disease: Comparison of Outcomes of Patients with Bulky Mediastinal Disease Versus Other Risk Factors; the Stanford V Experience. Blood. 110: 2316-2316. DOI: 10.1182/Blood.V110.11.2316.2316 |
0.451 |
|
| 2006 |
Brody JD, Advani R, Shin LK, Bingham DB, Rosenberg SA. Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: Diagnostic and therapeutic challenges. Annals of Hematology. 85: 817-20. PMID 16937096 DOI: 10.1007/S00277-006-0176-3 |
0.437 |
|
| 2006 |
Johnson DW, Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS. Hodgkin's disease limited to intrathoracic sites Cancer. 52: 8-13. PMID 6850546 DOI: 10.1002/1097-0142(19830701)52:1<8::Aid-Cncr2820520103>3.0.Co;2-Z |
0.724 |
|
| 2006 |
Advani RH, Hoppe RT, Rosenberg SA, Horning SJ. Incidence of secondary leukemia/myelodysplasia (AML/MDS) in Hodgkin's disease (HD) with three generations of therapy at Stanford University Journal of Clinical Oncology. 24: 7516-7516. DOI: 10.1200/Jco.2006.24.18_Suppl.7516 |
0.41 |
|
| 2005 |
Advani R, Maeda L, Hoppe RT, Breslin S, Rosenberg SA, Baer D, Mason J, Horning SJ. Assessment of Favorable (F) Versus Unfavorable (U) Early Stage Hodgkin’s Disease (HD); the Stanford V + Radiotherapy (RT) Experience. Blood. 106: 1932-1932. DOI: 10.1182/Blood.V106.11.1932.1932 |
0.419 |
|
| 2004 |
Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1454-9. PMID 15024027 DOI: 10.1200/Jco.2004.10.086 |
0.472 |
|
| 2004 |
Horning SJ, Hoppe RT, Advani R, Warnke R, Baer D, Mason J, Rosenberg SA. Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients. Blood. 104: 308-308. DOI: 10.1182/Blood.V104.11.308.308 |
0.484 |
|
| 2002 |
Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 630-7. PMID 11821442 DOI: 10.1200/Jco.20.3.630 |
0.505 |
|
| 2001 |
Horning SJ, Negrin RS, Hoppe RT, Rosenberg SA, Chao NJ, Long GD, Brown BW, Blume KG. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood. 97: 404-409. PMID 11154216 DOI: 10.1182/Blood.V97.2.404 |
0.495 |
|
| 1999 |
Advani R, Warnke R, Rosenberg S. Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support Annals of Oncology. 10: 1207-1209. PMID 10586338 DOI: 10.1023/A:1008366721816 |
0.525 |
|
| 1997 |
Horning SJ, Hoppe RT, Mason J, Brown BW, Hancock SL, Baer D, Rosenberg SA. Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. Journal of Clinical Oncology. 15: 1736-1744. PMID 9164180 DOI: 10.1200/Jco.1997.15.5.1736 |
0.548 |
|
| 1997 |
Yuen AR, Rosenberg SA, Hoppe RT, Halpern JD, Horning SJ. Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease Blood. 89: 814-822. DOI: 10.1182/Blood.V89.3.814 |
0.49 |
|
| 1996 |
Rosenberg SA. The management of Hodgkin's disease: Half a century of change Annals of Oncology. 7: 555-560. PMID 8879367 DOI: 10.1093/Oxfordjournals.Annonc.A010670 |
0.553 |
|
| 1996 |
Horning SJ, Rosenberg SA, Hoppe RT. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update Annals of Oncology. 7: 105-108. PMID 8836420 DOI: 10.1093/Annonc/7.Suppl_4.S105 |
0.559 |
|
| 1995 |
Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. Journal of Clinical Oncology. 13: 1080-1088. PMID 7537796 DOI: 10.1200/Jco.1995.13.5.1080 |
0.585 |
|
| 1994 |
Rosenberg SA. The treatment of Hodgkin's disease? Annals of Oncology. 5: 17-21. PMID 8204516 DOI: 10.1093/Annonc/5.Suppl_2.S17 |
0.464 |
|
| 1994 |
Rosenberg SA. Modern combined modality management of Hodgkin's disease Current Opinion in Oncology. 6: 470-472. PMID 7827149 DOI: 10.1097/00001622-199409000-00004 |
0.493 |
|
| 1992 |
Rosenberg SA. Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's disease European Journal of Cancer. 28: 1379-1380. PMID 1515253 DOI: 10.1016/0959-8049(92)90524-6 |
0.389 |
|
| 1991 |
Rosenberg SA. The continuing challenge of Hodgkin's disease. Annals of Oncology. 2: 29-31. DOI: 10.1093/Annonc/2.Suppl_2.29 |
0.504 |
|
| 1991 |
Rosenberg SA. The malignant lymphomas called “non-Hodgkin's”: Thirty years of learning more and knowing less International Journal of Radiation Oncology Biology Physics. 21: 109. DOI: 10.1016/0360-3016(91)90428-7 |
0.326 |
|
| 1990 |
Cleary M, Rosenberg SA. The bcl-2 Gene, Follicular Lymphoma, and Hodgkin's Disease Journal of the National Cancer Institute. 82: 808-809. PMID 2185366 DOI: 10.1093/Jnci/82.10.808 |
0.412 |
|
| 1990 |
Chao NJ, Rosenberg SA, Horning SJ. CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma Blood. 76: 1293-1298. DOI: 10.1182/Blood.V76.7.1293.1293 |
0.488 |
|
| 1989 |
Leibenhaut MH, Hoppe RT, Efron B, Halpern J, Nelsen T, Rosenberg SA. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease Journal of Clinical Oncology. 7: 81-91. PMID 2909669 DOI: 10.1200/Jco.1989.7.1.81 |
0.518 |
|
| 1989 |
Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology. 7: 1630-1636. PMID 2809679 DOI: 10.1200/Jco.1989.7.11.1630 |
0.434 |
|
| 1989 |
Hoppe RT, Horning SJ, Hancock SL, Rosenberg SA. Current Stanford clinical trials for Hodgkin's disease. Recent Results in Cancer Research. 117: 182-190. PMID 2690227 DOI: 10.1007/978-3-642-83781-4_19 |
0.427 |
|
| 1989 |
Hancockdg SL, Hoppe RT, Horning SJ, Rosenberg SA. Cardiovascular mortality following treatment of Hodgkin's disease International Journal of Radiation Oncology Biology Physics. 17: 141. DOI: 10.1016/0360-3016(89)90681-0 |
0.402 |
|
| 1988 |
Rosenberg SA. Exploratory laparotomy and splenectomy for Hodgkin's disease: A commentary Journal of Clinical Oncology. 6: 574-575. PMID 3357003 DOI: 10.1200/Jco.1988.6.4.574 |
0.476 |
|
| 1988 |
Hancock SL, Hoppe RT, Horning SJ, Rosenberg SA. Intercurrent Death after Hodgkin Disease Therapy in Radiotherapy and Adjuvant MOPP Trials Annals of Internal Medicine. 109: 183-189. PMID 3291657 DOI: 10.7326/0003-4819-109-3-183 |
0.433 |
|
| 1988 |
Horning SJ, Hoppe RT, Hancock SL, Rosenberg SA. Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. Journal of Clinical Oncology. 6: 1822-1831. PMID 2462025 DOI: 10.1200/Jco.1988.6.12.1822 |
0.536 |
|
| 1987 |
Rosenberg SA, Hoppe RT, Leibenhaut MH. Role of the spleen in the transdiaphragmatic spread of hodgkin's disease The American Journal of Medicine. 83: 367-368. PMID 3618641 DOI: 10.1016/0002-9343(87)90720-0 |
0.452 |
|
| 1987 |
Leibenhaut MH, Hoppe RT, Varghese A, Rosenberg SA. Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients. Journal of Clinical Oncology. 5: 1050-1055. PMID 3598609 DOI: 10.1200/Jco.1987.5.7.1050 |
0.571 |
|
| 1987 |
Roach M, Kapp DS, Rosenberg SA, Hoppe RT. Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease. Journal of Clinical Oncology. 5: 550-555. PMID 3559648 DOI: 10.1200/Jco.1987.5.4.550 |
0.576 |
|
| 1987 |
Rosenberg SA. Autologous bone marrow transplantation in non-Hodgkin's lymphoma New England Journal of Medicine. 316: 1541-1542. PMID 3295545 DOI: 10.1056/Nejm198706113162409 |
0.465 |
|
| 1987 |
Hancock SL, Rosenberg SA, Horning SJ, Hoppe RT. Intercurrent death following Hodgkin's disease therapy: radiotherapy, adjuvant mopp trials International Journal of Radiation Oncology Biology Physics. 13: 92. DOI: 10.1016/0360-3016(87)91032-7 |
0.463 |
|
| 1986 |
Coleman CN, Picozzi VJ, Cox RS, McWhirter K, Weiss LM, Cohen JR, Yu KP, Rosenberg SA. Treatment of lymphoblastic lymphoma in adults. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1628-37. PMID 3772416 DOI: 10.1200/Jco.1986.4.11.1628 |
0.442 |
|
| 1986 |
Bernstein JI, Coleman CN, Strickler JG, Dorfman RF, Rosenberg SA. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). Journal of Clinical Oncology. 4: 847-858. PMID 3711961 DOI: 10.1200/Jco.1986.4.6.847 |
0.548 |
|
| 1986 |
Kaminski MS, Coleman CN, Colby TV, Cox RS, Rosenberg SA. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy Annals of Internal Medicine. 104: 747-756. PMID 3518561 DOI: 10.7326/0003-4819-104-6-747 |
0.456 |
|
| 1985 |
Herman TS, Hoppe RT, Donaldson SS, Cox RS, Rosenberg SA, Kaplan HS. Late Relapse Among Patients Treated for Hodgkin's Disease Annals of Internal Medicine. 102: 292-297. PMID 3970468 DOI: 10.7326/0003-4819-102-3-292 |
0.691 |
|
| 1985 |
Tucker MA, Misfeldt D, Coleman CN, Clark WH, Rosenberg SA. Cutaneous malignant melanoma after Hodgkin's disease. Annals of Internal Medicine. 102: 37-41. PMID 3966743 DOI: 10.7326/0003-4819-102-1-37 |
0.452 |
|
| 1985 |
Rosenberg SA, Kaplan HS. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984 International Journal of Radiation Oncology, Biology, Physics. 11: 5-22. PMID 3881376 DOI: 10.1016/0360-3016(85)90357-8 |
0.695 |
|
| 1985 |
Schreiber DP, Jacobs C, Rosenberg SA, Cox RS, Hoppe RT. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas☆ International Journal of Radiation Oncology Biology Physics. 11: 31-36. PMID 3838166 DOI: 10.1016/0360-3016(85)90359-1 |
0.562 |
|
| 1985 |
Rosenberg SA. Laparotomy and splenectomy in Hodgkin's disease: A reappraisal after twenty years Scandinavian Journal of Haematology. 34: 289-292. PMID 2408324 DOI: 10.1111/J.1600-0609.1985.TB00750.X |
0.375 |
|
| 1984 |
Austin-Seymour MM, Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS. Hodgkin's Disease in Patients Over Sixty Years Old Annals of Internal Medicine. 100: 13-18. PMID 6691638 DOI: 10.7326/0003-4819-100-1-13 |
0.684 |
|
| 1984 |
Castellino R, Hoppe R, Blank N, Young S, Neumann C, Rosenberg S, Kaplan H. Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease American Journal of Roentgenology. 143: 37-41. PMID 6610327 DOI: 10.2214/Ajr.143.1.37 |
0.576 |
|
| 1984 |
Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas New England Journal of Medicine. 311: 1471-1475. PMID 6548796 DOI: 10.1056/Nejm198412063112303 |
0.524 |
|
| 1984 |
Rosenberg SA. The role of chemotherapy in the management of early stage Hodgkin's disease. Hematological Oncology. 2: 61-63. PMID 6203821 DOI: 10.1002/Hon.2900020107 |
0.478 |
|
| 1984 |
Tseng A, Coleman CN, Cox RS, Colby TV, Turner RR, Horning SJ, Rosenberg SA. The treatment of malignant histiocytosis. Blood. 64: 48-53. DOI: 10.1182/Blood.V64.1.48.Bloodjournal64148 |
0.528 |
|
| 1984 |
Rosenberg SA. The Stanford randomized clinical trials of the management of Hodgkin's disease: 1962–1984 International Journal of Radiation Oncology Biology Physics. 10: 75. DOI: 10.1016/0360-3016(84)90655-2 |
0.373 |
|
| 1983 |
Mead GM, Mackintosh FR, Burke JS, Rosenberg SA. Late relapse from complete remission in nodular and diffuse histiocytic lymphoma Cancer. 52: 1356-1359. PMID 6616403 DOI: 10.1002/1097-0142(19831015)52:8<1356::Aid-Cncr2820520803>3.0.Co;2-M |
0.5 |
|
| 1983 |
Paryani S, Hoppe RT, Burke JS, Sneed P, Dawley D, Cox RS, Rosenberg SA, Kaplan HS. Extralymphatic involvement in diffuse non-Hodgkin's lymphoma Journal of Clinical Oncology. 1: 682-688. PMID 6422003 DOI: 10.1200/Jco.1983.1.11.682 |
0.7 |
|
| 1983 |
Paryani SB, Hoppe RT, Cox RS, Colby TV, Rosenberg SA, Kaplan HS. Analysis of non‐Hodgkin's lymphomas with nodular and favorable histologies, stages I and II Cancer. 52: 2300-2307. PMID 6416664 DOI: 10.1002/1097-0142(19831215)52:12<2300::Aid-Cncr2820521224>3.0.Co;2-Y |
0.679 |
|
| 1983 |
Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA. Histologic conversion in the non-Hodgkin's lymphomas. Journal of Clinical Oncology. 1: 11-16. PMID 6366124 DOI: 10.1200/Jco.1983.1.1.11 |
0.675 |
|
| 1983 |
Mead GM, Kushlan P, O'Neil M, Burke JS, Rosenberg SA. Clinical aspects of non‐Hodgkin's lymphomas presenting with discordant histologic subtypes Cancer. 52: 1496-1501. PMID 6352001 DOI: 10.1002/1097-0142(19831015)52:8<1496::Aid-Cncr2820520827>3.0.Co;2-1 |
0.51 |
|
| 1982 |
Mackintosh FR, Colby TV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, Rosenberg SA, Kaplan HS. Central Nervous System Involvement in non-Hodgkin 's Lymphoma: An Analysis of 105 Cases Cancer. 49: 586-595. PMID 7059915 DOI: 10.1002/1097-0142(19820201)49:3<586::Aid-Cncr2820490331>3.0.Co;2-C |
0.658 |
|
| 1982 |
Mead GM, Harker WG, Kushlan P, Rosenberg SA. Single agent palliative chemotherapy for end-stage Hodgkin's disease Cancer. 50: 829-835. PMID 6178495 DOI: 10.1002/1097-0142(19820901)50:5<829::Aid-Cncr2820500504>3.0.Co;2-R |
0.572 |
|
| 1982 |
Horning SJ, Levine JF, Miller RA, Rosenberg SA, Merigan TC. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. Jama. 247: 1718-22. PMID 6174742 DOI: 10.1001/Jama.1982.03320370032025 |
0.312 |
|
| 1982 |
Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the Pregnant Patient with Hodgkinʼs Disease Obstetrical & Gynecological Survey. 37: 661. DOI: 10.1097/00006254-198211000-00006 |
0.596 |
|
| 1982 |
Gray GM, Rosenberg SA, Cooper AD, Gregory PB, Stein DT, Herzenberg H. Lymphomas involving the gastrointestinal tract Gastroenterology. 82: 143-152. DOI: 10.1016/0016-5085(82)90138-X |
0.492 |
|
| 1981 |
Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the Pregnant Patient with Hodgkin's Disease Annals of Internal Medicine. 95: 669-675. PMID 7305142 DOI: 10.7326/0003-4819-95-6-669 |
0.648 |
|
| 1981 |
Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female Reproductive Potential after Treatment for Hodgkin's Disease The New England Journal of Medicine. 304: 1377-1382. PMID 7231460 DOI: 10.1056/Nejm198106043042301 |
0.605 |
|
| 1981 |
Torti FM, Portlock CS, Rosenberg SA, Kaplan HS. Extralymphatic Hodgkin's disease. Prognosis and response to therapy. The American Journal of Medicine. 70: 487-492. PMID 7011010 DOI: 10.1016/0002-9343(81)90570-2 |
0.695 |
|
| 1981 |
Louie AC, Gallagher JG, Sikora K, Levy R, Rosenberg SA, Merigan TC. Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. Blood. 58: 712-8. PMID 6168319 DOI: 10.1182/Blood.V58.4.712.712 |
0.509 |
|
| 1981 |
Hoppe RT, Kushlan P, Kaplan HS, Rosenberg SA, Brown BW. The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood. 58: 592-598. DOI: 10.1182/Blood.V58.3.592.Bloodjournal583592 |
0.692 |
|
| 1981 |
Coleman C, Cohen J, Burke J, Rosenberg S. Lymphoblastic lymphoma in adults: results of a pilot protocol. Blood. 57: 679-684. DOI: 10.1182/Blood.V57.4.679.679 |
0.541 |
|
| 1981 |
Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female Reproductive Potential after Treatment for Hodgkinʼs Disease Obstetrical & Gynecological Survey. 36: 586-587. DOI: 10.1097/00006254-198110010-00026 |
0.541 |
|
| 1981 |
Castellino RA, Noon M, Young S, Blank N, Hoppe R, Rosenberg S, Kaplan HS. An Evaluation Of Abdominal Ct Scanning In Initial Staging Of Hodgkin's And Non-hodgkin's Lymphoma: Progress Report Investigative Radiology. 16: 415. DOI: 10.1097/00004424-198109000-00110 |
0.614 |
|
| 1980 |
Krikorian JG, Portlock CS, Cooney DP, Rosenberg SA. Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer. 46: 2093-2099. PMID 7427915 DOI: 10.1002/1097-0142(19801101)46:9<2093::Aid-Cncr2820460931>3.0.Co;2-4 |
0.555 |
|
| 1980 |
Hoppe RT, Rosenberg SA, Kaplan HS, Cox RS. Prognostic factors in pathological stage IIIA Hodgkin's disease. Cancer. 46: 1240-1246. PMID 7214305 DOI: 10.1002/1097-0142(19800901)46:5<1240::Aid-Cncr2820460526>3.0.Co;2-T |
0.657 |
|
| 1980 |
Rosenfelt F, Rosenberg SA. Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions the stanford experience Cancer. 45: 2188-2193. PMID 6989486 DOI: 10.1002/1097-0142(19800415)45:8<2188::Aid-Cncr2820450830>3.0.Co;2-E |
0.518 |
|
| 1980 |
Notter DT, Grossman PL, Rosenberg SA, Remington JS. Infections in Patients with Hodgkin's Disease: A Clinical Study of 300 Consecutive Adult Patients Clinical Infectious Diseases. 2: 761-800. PMID 6763305 DOI: 10.1093/Clinids/2.5.761 |
0.479 |
|
| 1980 |
Acker BD, Hoppe RT, Rosenberg SA, Kaplan HS. Prognostic factors after relapse in non-Hodgkin's lymphoma of favorable histologic type International Journal of Radiation Oncology Biology Physics. 6: 1349. DOI: 10.1016/0360-3016(80)90431-9 |
0.661 |
|
| 1979 |
Ribas-Mundo M, Rosenberg SA. The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 200 consecutive untreated patients with non-Hodgkin's lymphoma. European Journal of Cancer. 15: 941-952. PMID 488154 DOI: 10.1016/0014-2964(79)90277-9 |
0.467 |
|
| 1979 |
Krikorian JG, Portlock CS, Rosenberg SA, Kaplan HS. Hodgkin's disease, stages I and II occurring below the diaphragm. Cancer. 43: 1866-1871. PMID 445373 DOI: 10.1002/1097-0142(197905)43:5<1866::Aid-Cncr2820430541>3.0.Co;2-5 |
0.703 |
|
| 1979 |
Rosenberg SA. Current concepts in cancer. Non-Hodgkin's lymphoma: Selection of treatment on the basis of histologic type New England Journal of Medicine. 301: 924-928. PMID 384253 DOI: 10.1056/Nejm197910253011706 |
0.438 |
|
| 1979 |
Hoppe RT, Portlock CS, Glatstein E, Rosenberg SA, Kaplan HS. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease Cancer. 43: 472-481. PMID 369676 DOI: 10.1002/1097-0142(197902)43:2<472::Aid-Cncr2820430211>3.0.Co;2-W |
0.689 |
|
| 1979 |
Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types Annals of Internal Medicine. 90: 10-13. PMID 369420 DOI: 10.7326/0003-4819-90-1-10 |
0.575 |
|
| 1979 |
Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease The New England Journal of Medicine. 300: 452-458. PMID 366418 DOI: 10.1056/Nejm197903013000902 |
0.712 |
|
| 1979 |
Hoppe RT, Rosenberg SA, Kaplan HS. The treatment of stage III – IV non-Hodgkin'S lymphoma of “favorable” histologic type. A randomized comparison of whole body irradiation, combination chemotherapy, and single agent chemotherapy International Journal of Radiation Oncology Biology Physics. 5: 164. DOI: 10.1016/0360-3016(79)90478-4 |
0.646 |
|
| 1978 |
Rosenberg SA. The management of Hodgkin's disease. The New England Journal of Medicine. 299: 1246-1247. PMID 714082 DOI: 10.1056/Nejm197811302992209 |
0.408 |
|
| 1978 |
Rosenberg SA, Ribas-Mundo M, Goffinet DR, Kaplan HS. Staging in Adult Non-Hodgkin’s Lymphomas Recent Results in Cancer Research. 65: 51-57. PMID 370942 DOI: 10.1007/978-3-642-81249-1_7 |
0.452 |
|
| 1978 |
Elias L, Portlock CS, Rosenberg SA. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) Cancer. 42: 1705-1710. PMID 361209 DOI: 10.1002/1097-0142(197810)42:4<1705::Aid-Cncr2820420408>3.0.Co;2-P |
0.542 |
|
| 1978 |
Breiter DN, Diasio RB, Neifeld JP, Roush ML, Rosenberg SA. Serum copper and zinc measurement in patients with osteogenic sarcoma. Cancer. 42: 598-602. PMID 307981 DOI: 10.1002/1097-0142(197808)42:2<598::AID-CNCR2820420228>3.0.CO;2-P |
0.306 |
|
| 1978 |
Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS. Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials. Cancer. 42: 991-1000. PMID 99226 DOI: 10.1002/1097-0142(197808)42:2+<991::Aid-Cncr2820420722>3.0.Co;2-A |
0.711 |
|
| 1978 |
Krikorian JG, Portlock CS, Rosenberg SA. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy Cancer. 41: 2107-2111. PMID 77716 DOI: 10.1002/1097-0142(197806)41:6<2107::Aid-Cncr2820410606>3.0.Co;2-L |
0.546 |
|
| 1978 |
Porzig KJ, Portlock CS, Robertson A, Rosenberg SA. Treatment of advanced Hodgkin's disease with B‐CAVe following MOPP failure Cancer. 41: 1670-1675. PMID 77180 DOI: 10.1002/1097-0142(197805)41:5<1670::Aid-Cncr2820410504>3.0.Co;2-Y |
0.489 |
|
| 1978 |
Portlock C, Rosenberg S, Glatstein E, Kaplan H. Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III. Blood. 51: 825-833. DOI: 10.1182/Blood.V51.5.825.825 |
0.676 |
|
| 1977 |
Coleman CN, Williams CJ, Flint A, Glatstein EJ, Rosenberg SA, Kaplan HS. Hematologic neoplasia in patients treated for Hodgkin's disease. The New England Journal of Medicine. 297: 1249-52. PMID 917069 DOI: 10.1056/NEJM197712082972303 |
0.503 |
|
| 1977 |
Weller SA, Glatstein E, Castellino RA, Kaplan HS, Rosenberg SA. Initial relapse in previously treated Hodgkin's disease--II retrograde transdiaphragmatic extension. International Journal of Radiation Oncology Biology Physics. 2: 863-872. PMID 591406 DOI: 10.1016/0360-3016(77)90184-5 |
0.735 |
|
| 1976 |
Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS. Pediatric hodgkin's disease. II. Results of therapy. Cancer. 37: 2436-2447. PMID 1260726 DOI: 10.1002/1097-0142(197605)37:5<2436::AID-CNCR2820370537>3.0.CO;2 |
0.707 |
|
| 1976 |
Portlock CS, Rosenberg SA. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non‐Hodgkin's lymphomas Cancer. 37: 1275-1282. PMID 1260652 DOI: 10.1002/1097-0142(197603)37:3<1275::Aid-Cncr2820370307>3.0.Co;2-M |
0.55 |
|
| 1976 |
Weller SA, Glatstein E, Kaplan HS, Rosenberg SA. Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment† Cancer. 37: 2840-2846. PMID 949704 DOI: 10.1002/1097-0142(197606)37:6<2840::Aid-Cncr2820370640>3.0.Co;2-H |
0.724 |
|
| 1976 |
Portlock C, Rosenberg S, Glatstein E, Kaplan H. Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial Blood. 47: 747-756. DOI: 10.1182/Blood.V47.5.747.Bloodjournal475747 |
0.709 |
|
| 1975 |
Rosenberg SA. Combination chemotherapy in Hodgkin's disease: relation to radiotherapy Bibliotheca Haematologica. 731-735. PMID 1164407 DOI: 10.1159/000397595 |
0.505 |
|
| 1975 |
Kaplan HS, Rosenberg SA. The management of Hodgkin's disease. Cancer. 36: 796-803. PMID 1157037 DOI: 10.1002/1097-0142(197508)36:2+<796::Aid-Cncr2820360825>3.0.Co;2-N |
0.67 |
|
| 1975 |
Rosenberg SA, Kaplan HS. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy Cancer. 35: 55-63. PMID 803252 DOI: 10.1002/1097-0142(197501)35:1<55::Aid-Cncr2820350108>3.0.Co;2-G |
0.696 |
|
| 1974 |
Glatstein E, Kim H, Donaldson SS, Dorfman RF, Gribble TJ, Wilbur JR, Rosenberg SA, Kaplan HS. Non-Hodgkin's lymphomas. VI. Results of treatment in childhood Cancer. 34: 204-211. PMID 4599461 DOI: 10.1002/1097-0142(197407)34:1<204::Aid-Cncr2820340131>3.0.Co;2-2 |
0.718 |
|
| 1974 |
Castellino RA, Glatstein E, Turbow MM, Rosenberg S, Kaplan HS. Latent Radiation Injury of Lungs or Heart Activated by Steroid Withdrawal Annals of Internal Medicine. 80: 593-599. PMID 4207345 DOI: 10.7326/0003-4819-80-5-593 |
0.557 |
|
| 1973 |
Goffinet DR, Castellino RA, Kim H, Dorfman RF, Fuks Z, Rosenberg SA, Nelsen T, Kaplan HS. Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer. 32: 672-681. PMID 4726967 DOI: 10.1002/1097-0142(197309)32:3<672::Aid-Cncr2820320321>3.0.Co;2-Q |
0.675 |
|
| 1973 |
Moore MR, Jones SE, Bull JM, William LA, Rosenberg SA. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients Cancer. 32: 52-60. PMID 4716784 DOI: 10.1002/1097-0142(197307)32:1<52::Aid-Cncr2820320107>3.0.Co;2-S |
0.68 |
|
| 1973 |
Rosenberg SA. A rare type of Hodgkin's disease New England Journal of Medicine. 288: 789-790. PMID 4688719 DOI: 10.1056/Nejm197304122881512 |
0.467 |
|
| 1973 |
Jones SE, Fuks Z, Kaplan HS, Rosenberg SA. Non-Hodgkin's lymphomas. V. Results of radiotherapy. Cancer. 32: 682-691. PMID 4580229 DOI: 10.1002/1097-0142(197309)32:3<682::Aid-Cncr2820320322>3.0.Co;2-M |
0.767 |
|
| 1973 |
Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H. Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases Cancer. 31: 806-823. PMID 4574662 DOI: 10.1002/1097-0142(197304)31:4<806::Aid-Cncr2820310408>3.0.Co;2-1 |
0.729 |
|
| 1972 |
Moore MR, Bull JM, Jones SE, Rosenberg SA, Kaplan HS. Sequential Radiotherapy and Chemotherapy in the Treatment of Hodgkin's Disease: A Progress Report Annals of Internal Medicine. 77: 1-9. PMID 5052446 DOI: 10.7326/0003-4819-77-1-1 |
0.743 |
|
| 1972 |
Donaldson SS, Moore MR, Rosenberg SA, Vosti KL. Characterization of postsplenectomy bacteremia among patients with and without lymphoma. The New England Journal of Medicine. 287: 69-71. PMID 5031388 DOI: 10.1056/Nejm197207132870203 |
0.488 |
|
| 1972 |
Jones SE, Rosenberg SA, Kaplan HS. Non-Hodgkin's lymphomas. I. Bone marrow involvement. Cancer. 29: 954-960. PMID 5017364 DOI: 10.1002/1097-0142(197204)29:4<954::Aid-Cncr2820290442>3.0.Co;2-5 |
0.685 |
|
| 1972 |
Rosenberg SA. Place of Splenectomy in Evaluation and Management Jama: the Journal of the American Medical Association. 222: 1296-1298. PMID 4678148 DOI: 10.1001/Jama.1972.03210100044014 |
0.413 |
|
| 1972 |
Rosenberg SA, Moore MR, Bull JMC, Jones SE, Kaplan HS. Combination chemotherapy and radiotherapy for Hodgkin's disease Cancer. 30: 1505-1510. PMID 4641759 DOI: 10.1002/1097-0142(197212)30:6<1505::Aid-Cncr2820300614>3.0.Co;2-L |
0.747 |
|
| 1972 |
Rosenberg SA. Splenectomy in the management of Hodgkin's disease British Journal of Haematology. 23: 271-276. PMID 4562675 DOI: 10.1111/J.1365-2141.1972.Tb08872.X |
0.409 |
|
| 1972 |
Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF. Non-Hodgkin's lymphomas. II. Single agent chemotherapy. Cancer. 30: 31-38. PMID 4557278 DOI: 10.1002/1097-0142(197207)30:1<31::Aid-Cncr2820300106>3.0.Co;2-A |
0.74 |
|
| 1972 |
Jones SE, Kaplan HS, Rosenberg SA. Non-Hodgkin's Lymphomas Radiology. 103: 657-662. PMID 4553978 DOI: 10.1148/103.3.657 |
0.759 |
|
| 1970 |
Glatstein E, Trueblood HW, Enright LP, Rosenberg SA, Kaplan HS. Surgical Staging of Abdominal Involvement in Unselected Patients with Hodgkin's Disease Radiology. 97: 425-432. PMID 5481152 DOI: 10.1148/97.2.425 |
0.594 |
|
| 1969 |
Glatstein E, Guernsey JM, Rosenberg SA, Kaplan HS. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer. 24: 709-18. PMID 4980685 DOI: 10.1002/1097-0142(196910)24:4<709::Aid-Cncr2820240408>3.0.Co;2-E |
0.599 |
|
| 1968 |
Kaplan HS, Rosenberg SA. Cure of Hodgkin's disease and other malignant lymphomas Postgraduate Medicine. 43: 146-153. PMID 5648653 DOI: 10.1080/00325481.1968.11693253 |
0.667 |
|
| 1968 |
Kaplan HS, Rosenberg SA. The Cure of Malignant Lymphomas Hospital Practice. 3: 28-33. DOI: 10.1080/21548331.1968.11707830 |
0.584 |
|
| 1966 |
Kaplan HS, Rosenberg SA. The Treatment of Hodgkin's Disease Medical Clinics of North America. 50: 1591-1610. PMID 5339193 DOI: 10.1016/S0025-7125(16)33107-8 |
0.63 |
|
| 1966 |
Rosenberg SA. Staging of Hodgkin's Disease Radiology. 87: 145-147. DOI: 10.1148/87.1.145J |
0.478 |
|
| 1961 |
ROSENBERG SA, DIAMOND HD, JASLOWITZ B, CRAVER LF. Lymphosarcoma: a review of 1269 cases. Medicine. 40: 31-84. PMID 13743408 DOI: 10.1097/00005792-196102000-00002 |
0.53 |
|
| 1960 |
ROSENBERG SA, DIAMOND HD, CRAVER LF. Lymphosarcoma: the effects of therapy and survival in 1,269 patients in a review of 30 years' experience. Annals of Internal Medicine. 53: 877-97. PMID 13743407 DOI: 10.7326/0003-4819-53-5-877 |
0.655 |
|
| 1958 |
ROSENBERG SA, DIAMOND HD, DARGEON HW, CRAVER LF. Lymphosarcoma in childhood. The New England Journal of Medicine. 259: 505-12. PMID 13578093 DOI: 10.1056/Nejm195809112591101 |
0.637 |
|
| Show low-probability matches. |